Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use. Crawford M, van Wyk J, Aboud M, Vannappagari V, et al. J Acquir Immune Defic Syndr 2020;83:e2-e5.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Crawford M, van Wyk J, Aboud M, Vannappagari V, et al. Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use. J Acquir Immune Defic Syndr 2020;83:e2-e5.
PMID: 31809366